Susanna Magee, MD
Family Medicine · Pawtucket, RINPI 1487638003
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations.
Across 62 payments — averaging $23.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$233
- Astellas Pharma US Inc$206
- AbbVie$138
- Sumitomo Pharma America, Inc.$135
- Sage Therapeutics, LLC$125
- Cranial Technologies, Inc$103
- plus $496 from 13 others
What the payments were for
- Food & beverage$1,436100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 10 | $233 |
| Astellas Pharma US Inc | 7 | $206 |
| AbbVie | 6 | $138 |
| Sumitomo Pharma America, Inc. | 6 | $135 |
| Sage Therapeutics, LLC | 5 | $125 |
| Cranial Technologies, Inc | 5 | $103 |
| Exeltis, USA Inc. | 3 | $91 |
| Bayer | 4 | $82 |
| Myovant Sciences Inc. | 3 | $56 |
| Mayne Pharma Commercial LLC | 2 | $44 |
| Davol Inc. | 1 | $37 |
| Coopersurgical, Inc. | 2 | $36 |
| Pfizer | 2 | $34 |
| Medicomp Inc | 1 | $32 |
| Lilly USA, LLC | 1 | $28 |
| Merck | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Watermark Medical, Inc. | 1 | $14 |
| Echosens North America, Inc. | 1 | $12 |
How this compares
$1,436 in reported general payments places this provider in the 80th percentile of 222 family medicine providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 13 | $12,130 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,926 |
| Pregabalin | 14 | $1,420 |
| Omeprazole | 67 | $1,133 |
| Gabapentin | 56 | $1,040 |
| Lisinopril | 88 | $840 |
| Sertraline Hcl | 70 | $826 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $780 |
| Trazodone Hcl | 77 | $773 |
| Losartan Potassium | 76 | $761 |
| Levothyroxine Sodium | 46 | $648 |
| Atorvastatin Calcium | 53 | $610 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $592 |
| Cyclobenzaprine Hcl | 44 | $538 |
| Valsartan | 13 | $528 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Pawtucket
- Mary SutterPawtucket$13K
- Leonard BertheauPawtucket$11K
- Caroline RichardsonPawtucket$2K
- Michael DickPawtucket$2K
- Gina la ProvaCumberland$778K
- Wilfredo Giordano-PerezJohnston$351K
- Martin MinerProvidence$124K
- Frank la FaziaWest Warwick$19K
- Jamiel AmbradWakefield$18K
- Jason AustinJohnston$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.